Table 1.
Study population. Overview of gender, age, size, weight, body mass index, and primary condition of all included patients. The interval between dual-energy computed tomography (CT) and magnetic resonance imaging scan in days, as well as the clinical CT indication, is provided
| Patient | Gender | Age | Height [m] | Weight [kg] | Body mass index [kg/m2] | Time interval CT and MR [d] | Primary condition | CT indication |
|---|---|---|---|---|---|---|---|---|
| 1 | f | 60 | 1.68 | 82 | 29.1 | 2 | Arterial hypertension | Bleeding? |
| 2 | f | 33 | 1.61 | 85 | 32.8 | 4 | Post-partum (caesarean) | Infected hematoma? |
| 3 | m | 80 | 1.73 | 78 | 26.1 | 4 | Hemiparesis SP stroke, COPD, DM type II, alcohol abuse | Diverticulitis? perforation? |
| 4 | f | 53 | 1.77 | 67 | 21.4 | 4 | Pancreas carcinoma (pT2, N2 M0) | Current staging |
| 5 | f | 81 | 1.62 | 85 | 32.4 | 3 | PAD stage IV, COPD, DM type II, alcohol abuse, CKD stage IV, steatosis hepatis | SP aortic prosthesis removal |
| 6 | m | 77 | 1.80 | 75 | 23.2 | 2 | Hemiparesis, NYHA III, COPD D, SCLC (pT1c, N0, M0), CLL | Acute abdomen |
| 7 | f | 55 | 1.67 | 71,2 | 25.5 | 2 | Malignant melanoma (pT2b, N2c, M1c), bedridden (epidural metastases), hepatic steatosis | Bowel obstruction? |
| 8 | m | 65 | 1.76 | 53 | 17.1 | 1 | NSCLC (cT4, cN3, cM1c), SP NSTEMI, SP hypoxic encephalopathy | Focus of infection? abscess? GI dysfunction? |
| 9 | f | 58 | 1.83 | 72 | 21.5 | 4 | Aggressive fibromatosis | Ulcus perforation? pancreatitis? |
| 10 | m | 52 | 1.86 | 103 | 29.8 | 3 | DM, Hypercholesterolemia, steatosis hepatis | Pancreatitis? abdominal focus? |
| 11 | m | 37 | 1.94 | 88 | 23.4 | 2 | Glioblastoma stage IV | Focus of infection? |
| 12 | f | 58 | 1.56 | 43 | 17.7 | 1 | Non-Hodgkin lymphoma relapse (Ann-Arbor IV), HIV | Focus of infection? abscess? |
| 13 | f | 68 | 1.6 | 72 | 28.1 | 1 | Breast cancer (pT2, pN2a, M1), SP intestinal perforation | Cholestasis? abscess? |
| 14 | f | 83 | 1.63 | 67 | 25.2 | 4 | Klatskin tumor type IIIa/IV | Perfusion deficit? portal vein thrombosis? cholestasis? |
| 15 | m | 62 | 1.78 | 109 | 34.4 | 2 | Prostate cancer (pT1b, N0, M0), SP ileum perforation, hepatic steatosis | Focus of infection? |
| 16 | m | 51 | 1.79 | 89 | 27.8 | 2 | Chronic hepatitis C, liver cirrhosis, AKI | Portal vein thrombosis? hepatic decompensation? |
| 17 | m | 27 | 1.78 | 55 | 17.4 | 36 | SP multiples abscesses, SP partial lung resection, DM type I | Abscess? |
| 18 | m | 42 | 1.81 | 60,5 | 18.5 | 3 | PSC, cirrhosis, TIPS | Focus of infection? |
| 19 | m | 60 | 1.83 | 68 | 20.3 | 4 | SP papilloma resection | GI dysfunction? pancreatitis? |
| 20 | m | 32 | 1.81 | 73 | 22.3 | 3 | - | Appendicitis? |
| 21 | f | 57 | 1.71 | 72 | 24.6 | 1 | Colorectal cancer (pT3, N2b, M1a) | Progress? infection? |
Abbreviations: SP, status post; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; PAD, peripheral artery disease; CKD, chronic kidney disease; CLL, chronic lymphocytic leukemia; AKI, acute kidney injury; PSC, primary sclerosing cholangitis; TIPS, transjugular intrahepatic portosystemic shunt